Publications by authors named "C H Georgopoulos"

Article Synopsis
  • Phosphate binders like sucroferric oxyhydroxide and sevelamer carbonate are used in kidney replacement therapy (KRT) to lower serum phosphorus levels, which are linked to health issues in chronic kidney disease.
  • This study compared the effectiveness and safety of these two drugs through a meta-analysis of five randomized trials, finding no significant difference in reducing serum phosphorus between them.
  • However, sucroferric oxyhydroxide had a better gastrointestinal side effect profile, making it a preferable option for patients in KRT.
View Article and Find Full Text PDF

Laboratory-generated hybrids between phage λ and related phages played a seminal role in establishment of the λ model system, which, in turn, served to develop many of the foundational concepts of molecular biology, including gene structure and control. Important λ hybrids with phages 21 and 434 were the earliest of such phages. To understand the biology of these hybrids in full detail, we determined the complete genome sequences of phages 21 and 434.

View Article and Find Full Text PDF

Recombinational hybrids between phage λ and its relatives were instrumental in the beginnings of molecular biology. Here, we report the complete genome sequences of lambdoid phages 21 and 434 and three of their λ hybrids. In addition, we describe 434B, where the entire lysis gene region was replaced by cryptic prophage sequences.

View Article and Find Full Text PDF

The "POWERFUL" multicenter, retrospective, and prospective study investigated the effectiveness of pomalidomide plus low-dose dexamethasone (POM/LoDex) therapy in relapsed/refractory multiple myeloma in routine care in Greece. Ninety-nine eligible adult patients treated with POM/LoDex according to the approved label after having received ≥2 prior therapies, including lenalidomide and bortezomib, were consecutively enrolled between 16 November 2017 and 21 February 2019 in 18 hematology departments. Fifty patients (50.

View Article and Find Full Text PDF

Standardization of the use of next-generation sequencing for the diagnosis of rare neurological disorders has made it possible to detect potential disease-causing genetic variations, including de novo variants. However, the lack of a clear pathogenic relevance of gene variants poses a critical limitation for translating this genetic information into clinical practice, increasing the necessity to perform functional assays. Genetic screening is currently recommended in the guidelines for diagnosis of hypomyelinating leukodystrophies (HLDs).

View Article and Find Full Text PDF